(Q46378300)

21 December 2017

title

Normal macrophage function in infants receiving Intralipid by low-dose intermittent administration (English)

1 reference

21 December 2017

0 references

Strunk RC

1

1 reference

21 December 2017

Murrow BW

2

1 reference

21 December 2017

Thilo E

3

1 reference

21 December 2017

Kunke KS

4

1 reference

21 December 2017

Johnson EG

5

1 reference

21 December 2017

language of work or name

English

0 references

publication date

1 April 1985

1 reference

21 December 2017

The Journal of Pediatrics

published in

1 reference

21 December 2017

volume

106

1 reference

21 December 2017

page(s)

640-645

1 reference

21 December 2017

issue

4

1 reference

21 December 2017

Hepatic "intravenous fat pigment" in infants and children receiving lipid emulsion

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980094-9

Inhibition of In Vitro Synthesis of the Second (C2) and Fourth (C4) Components of Complement in Guinea Pig Peritoneal Macrophages by a Soybean Oil Emulsion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980094-9

Nutrition in low-birth-weight infants. I. Intravenous injection of fat emulsion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980094-9

Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980094-9

The reaction mechanism of human C5 in immune hemolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980094-9

Increased superoxide anion production by immunologically activated and chemically elicited macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980094-9

Activation of macrophages for enhanced release of superoxide anion and greater killing of Candida albicans by injection of muramyl dipeptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980094-9

Diminished bacterial defences with intralipid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980094-9

Decreased chemotactic and random migration of leukocytes during Intralipid infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980094-9

Intravenous lipid emulsions and human neutrophil function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980094-9

Inhibition of human lymphoproliferation by intravenous lipid emulsion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980094-9

Intralipid alters macrophage membrane fatty acid composition and inhibits complement (C2) synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980094-9

Pulmonary fat accumulation after intralipid infusion in the preterm infant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980094-9

Pulmonary arterial lipid deposit in newborn infants receiving intravenous lipid infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980094-9

Postmortem findings in three patients treated with intravenous fat emulsions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980094-9

Endotoxin clearance after intralipid infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980094-9

Malassezia pulmonary vasculitis in an infant on long-term Intralipid therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980094-9

10.1016/S0022-3476(85)80094-9

7 January 2021

Identifiers

DOI

1 reference

21 December 2017

PubMed ID

2984397

1 reference

21 December 2017